A5073917786- Head and Neck Cancer Studies
- Advanced Radiotherapy Techniques
- Prostate Cancer Diagnosis and Treatment
- Advances in Oncology and Radiotherapy
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Ear and Head Tumors
- Nausea and vomiting management
- Tracheal and airway disorders
- Innovations in Medical Education
- Cancer Diagnosis and Treatment
- Dysphagia Assessment and Management
- Management of metastatic bone disease
- Head and Neck Surgical Oncology
- Sarcoma Diagnosis and Treatment
- Lung Cancer Research Studies
- Oral health in cancer treatment
- Esophageal Cancer Research and Treatment
- Pediatric Pain Management Techniques
- Radiopharmaceutical Chemistry and Applications
- Pain Management and Opioid Use
- Voice and Speech Disorders
- Salivary Gland Tumors Diagnosis and Treatment
- Radiation Therapy and Dosimetry
- Pancreatic and Hepatic Oncology Research
Clinique Pasteur
2023-2025
Université de Tours
2015-2024
Centre Hospitalier Universitaire de Tours
2015-2024
Clinique du Pont Saint-Vaast
2023
Hôpital Bretonneau
2021
Groupe d'Oncologie Radiothérapie Tête et Cou
2015-2017
Centre Hospitalier de Bretagne Sud
2015
Institut Sainte Catherine
2015
Background:The purpose of GORTEC 2000–01 was to compare the long-term efficacy and safety induction chemotherapy with cisplatin (P) 5-fluorouracil (F) or without docetaxel (T) for larynx preservation.
Little information is currently available concerning young medical students desire to pursue a career in oncology, or their expectations.This project cross-sectional epidemiological study. A voluntary and anonymous questionnaire was distributed all oncologists studying France between the 2nd of October 2013 23rd February 2014.The overall response rate 75.6%. total 505 completed questionnaire. The main determining factors decision practice oncology were nature field (70.8%), depth variety...
6002 Background: To compare the long-term efficacy and safety of induction chemotherapy with cisplatin (P) 5-fluorouracil (F) or without docetaxel (T) for larynx preservation. Methods: Operable patients untreated stage-III -IV hypopharynx invasive squamous-cell carcinoma who required a total laryngectomy were randomly assigned to receive three cycles either TPF PF, followed by radiation therapy responders. The primary endpoint was 3-year larynx-preservation rate. Secondary endpoints included...
Due to the close proximity of prostate and rectum, rectal toxicity remains a major problem in patient treated by radiotherapy for adenocarcinoma. One method increasing distance between rectum is use spacer implanted into rectoprostatic space. This report describes long-term outcomes obtained with new ballon spacer. Patients curative low- or intermediate-risk adenocarcinoma, who underwent insertion ProSpace® (BioProtect Ltd, Tzur Yigal, Israel) rectal-prostate balloon spacer, were included....
Objective: The severity of breakthrough cancer pain (BTcP) impacts patients' quality life, increases the risk anxiety and depression, lowers functional capacities, may lead to poor compliance with treatments. aim current study was assess, in a real-life setting, patient satisfaction fentanyl-pectin-nasal-spray (FPNS) for BTcP management head neck (H&N) patients treated by radiotherapy. Materials Methods: This non-interventional, prospective conducted 92 adult H&N-cancer undergoing...
Abstract Background Due to the close proximity of prostate and rectum, rectal toxicity remains a major problem in patient treated by radiotherapy for adenocarcinoma. One method increasing distance between rectum is use spacer implanted into rectoprostatic space. This report describes long-term outcomes obtained with new ballon spacer. Methods Patients curative low- or intermediate-risk adenocarcinoma, who underwent insertion ProSpace® (BioProtect Ltd, Tzur Yigal, Israel) rectal-prostate...